Gamma Knife radiosurgery (GKRS) provides a safe and effective management option for patients with all types of pituitary adenomas. The long-term adverse effects of targeted radiation to the hypothalamic-pituitary axis in relationship to radiation dose remain unclear. In this retrospective review, the authors investigated the role of differential radiation doses in predicting long-term clinical outcomes and pituitary function after GKRS for pituitary adenomas.
A cohort of 236 patients with pituitary tumors (41.5% nonfunctioning, 58.5% functioning adenomas) was treated with GKRS between 1998 and 2015. Point dosimetric measurements, with no minimum volume, to 14 consistent points along the hypothalamus bilaterally, pituitary stalk, and normal pituitary were made. Statistical analyses were performed to determine the impact of doses to critical structures on clinical, radiological, and endocrine outcomes.
With a median follow-up duration of 42.9 months, 18.6% of patients developed new loss of pituitary function. The median time to endocrinopathy was 21 months (range 2–157 months). The median dose was 2.1 Gy to the hypothalamus, 9.1 Gy to the pituitary stalk, and 15.3 Gy to the normal pituitary. Increasing age (p = 0.015, HR 0.98) and ratio of maximum dose to the pituitary stalk over the normal pituitary gland (p = 0.013, HR 0.22) were independent predictors of new or worsening hypopituitarism in the multivariate analysis. Sex, margin dose, treatment volume, nonfunctioning adenoma status, or ratio between doses to the pituitary stalk and hypothalamus were not significant predictors.
GKRS offers a low rate of delayed pituitary insufficiency for pituitary adenomas. Doses to the hypothalamus are low and generally do not portend endocrine deficits. Patients who are treated with a high dose to the pituitary stalk relative to the normal gland are at higher risk of post-GKRS endocrinopathy. Point dosimetry to specific neuroanatomical structures revealed that a ratio of stalk-to-gland radiation dose of 0.8 or more significantly increased the risk of endocrinopathy following GKRS. Improvement in the gradient index toward the stalk and normal gland may help preserve endocrine function.
BradaM, RajanB, TraishD, AshleyS, Holmes-SellorsPJ, NusseyS, : The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. 38:571–578, 199310.1111/j.1365-2265.1993.tb02137.x8334743)| false
Cohen-InbarORameshAXuZVanceMLSchlesingerDSheehanJP: Gamma knife radiosurgery in patients with persistent acromegaly or Cushing’s disease: long-term risk of hypopituitarism. Clin Endocrinol (Oxf)84:524–5312016
FeiglGC, PistracherK, BergholdA, MokryM: Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. 113Suppl:153–159, 201010.3171/2010.8.GKS1095921222294)| false
GraffeoCSLinkMJBrownPDYoungWFJrPollockBE: Hypopituitarism after single-fraction pituitary adenoma radiosurgery: dosimetric analysis based on patients treated using contemporary techniques. Int J Radiat Oncol Biol Phys101:618–6232018
IwataH, SatoK, TatewakiK, YokotaN, InoueM, BabaY, : Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. 13:916–922, 20112166591810.1093/neuonc/nor055)| false
LangsenlehnerTStieglerCQuehenbergerFFeiglGCJakseGMokryM: Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol183:241–2472007
LangsenlehnerT, StieglerC, QuehenbergerF, FeiglGC, JakseG, MokryM, : Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. 183:241–247, 200710.1007/s00066-007-1706-117497095)| false
LosaM, ValleM, MortiniP, FranzinA, da PassanoCF, CenzatoM, : Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. 100:438–444, 200410.3171/jns.2004.100.3.043815035279)| false
MinnitiG, Jaffrain-ReaML, OstiM, CantoreG, EnriciRM: Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. 30:167–176, 200710.1007/s10143-007-0072-x17483973)| false
MokryM, Ramschak-SchwarzerS, SimbrunnerJ, GanzJC, PendlG: A six year experience with the postoperative radiosurgical management of pituitary adenomas. 72 (Suppl 1):88–100, 199910.1159/00005644410681696)| false
PollockBECochranJNattNBrownPDEricksonDLinkMJ: Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys70:1325–13292008
PomeraniecIJDallapiazzaRFXuZJaneJAJrSheehanJP: Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J Neurosurg125:202–2122016
PomeraniecIJ, DallapiazzaRF, XuZ, JaneJAJr, SheehanJP: Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. 125:202–212, 201610.3171/2015.5.JNS1558126517773)| false
SheehanJPNiranjanASheehanJMJaneJAJrLawsERKondziolkaD: Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg102:678–6912005
SheehanJP, NiranjanA, SheehanJM, JaneJAJr, LawsER, KondziolkaD, : Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. 102:678–691, 200510.3171/jns.2005.102.4.067815871511)| false
SicignanoG, LosaM, del VecchioA, CattaneoGM, PicozziP, BolognesiA, : Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. 104:119–124, 20122264765810.1016/j.radonc.2012.03.021)| false
SnellJW, SheehanJ, StroilaM, SteinerL: Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. 104:157–162, 200610.3171/jns.2006.104.1.15716509161)| false
StarkeRM, NguyenJH, RaineyJ, WilliamsBJ, ShermanJH, SavageJ, : Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission. 114:1399–1409, 20112121433510.3171/2010.11.JNS101193)| false
StarkeRMWilliamsBJJaneJAJrSheehanJP: Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg117:129–1352012
StarkeRM, WilliamsBJ, JaneJAJr, SheehanJP: Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. 117:129–135, 20122257774910.3171/2012.4.JNS112250)| false
TrifilettiDMXuZDuttaSWQuiñones-HinojosaAPetersonJVanceML: Endocrine remission after pituitary stereotactic radiosurgery: differences in rates of response for matched cohorts of Cushing Disease and acromegaly patients. Int J Radiat Oncol Biol Phys101:610–6172018
TrifilettiDM, XuZ, DuttaSW, Quiñones-HinojosaA, PetersonJ, VanceML, : Endocrine remission after pituitary stereotactic radiosurgery: differences in rates of response for matched cohorts of Cushing Disease and acromegaly patients. 101:610–617, 20182967852810.1016/j.ijrobp.2018.02.023)| false
WilliamsBJYenCPStarkeRMBasinaBNguyenJRaineyJ: Gamma Knife surgery for parasellar meningiomas: long-term results including complications, predictive factors, and progression-free survival. J Neurosurg114:1571–15772011
WowraBStummerW: Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg97 (5 Suppl):429–4322002
WowraB, StummerW: Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. 97 (5 Suppl):429–432, 200210.3171/jns.2002.97.supplement_5.042912507069)| false